V. Cogliandro

Immediate Versus Deferred Switching From a Boosted Protease Inhibitor–based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study

D. Podzamczer, B. Clotet, A. Winston, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Obesity Affects the Association of Bioelectrical Impedance Phase Angle With Mortality in People Living With HIV.

A. Westfall, M. Saag, J. Raper, 2020, The Journal of the Association of Nurses in AIDS Care : JANAC.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk: 48 week effects on subclinical cardiovascular disease.

D. Podzamczer, B. Clotet, A. Winston, 2020, The Journal of antimicrobial chemotherapy.

A multidisciplinary approach to screen the post-COVID-19 conditions

G. Foti, G. Citerio, M. Valsecchi, 2023, BMC Infectious Diseases.

Affronto multidisciplinare delle co-morbiditità HIV-correlate: esperienza e casistica di un centro italiano@@@Muldisciplinary approach to HIV-related co-morbidities: clinical experience of an Italian centre

A. Savoldi, T. Bini, L. Gazzola, 2016 .

Human Papilloma Virus Related Cancers in People Living with HIV

P. Bonfanti, N. Squillace, V. Cogliandro, 2023, Current Infectious Disease Reports.

Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study

M. Valsecchi, M. Lettino, P. Faverio, 2023, Internal and emergency medicine.